Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer.

Genes - 28 Oct 2021

Huang Taobi, Liang Yuan, Zhang Huiyun, Chen Xia, Wei Hui, Sun Weiming, Wang Yuping

Abstract excerpt

Tumor mutational burden (TMB) is considered a potential biomarker for predicting the response and effect of immune checkpoint inhibitors (ICIs). To find specific gene mutations related to TMB and the prognosis of patients, the frequently mutated genes in gastric cancer patients from TCGA and ICGC were obtained and the correlation between gene mutation, TMB, and prognosis was analyzed. Furthermore, to clarify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Chromosome Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Microsatellite Instability

Share to Protein Domains

Share to Stomach Neoplasms

Share to Survival Analysis

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 34828321
DOI: 10.3390/genes12111715
PMCID: PMC8623648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer.PMID 34828321Read ↗

CSMD1 mutation is associated with prognosis, tumor mutation burden, and immunophenotype in non-metastatic colorectal cancerSemantic proximity Read ↗

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer.Semantic proximity Read ↗

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric CancerSemantic proximity Read ↗

Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.Semantic proximity Read ↗

FAT4 Mutation is Related to Tumor Mutation Burden and Favorable Prognosis in Gastric CancerSemantic proximity Read ↗

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.Semantic proximity Read ↗

Continuous Prediction for Tumor Mutation Burden Based on Transcriptional Data in Gastrointestinal CancersSemantic proximity Read ↗

The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.Semantic proximity Read ↗

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer.Semantic proximity Read ↗

Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers.Semantic proximity Read ↗

Influence of Tumor Mutational Burden on Immune-infiltrating Cells in Stomach AdenocarcinomaSemantic proximity Read ↗

TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.